Healthcare startups’ funding environment this year may be characterized by a slower investment pace and more deal scrutiny, but that doesn’t mean that the healthcare innovation market is in a grim place, according to…
Continue Reading
What You Should Know:
– SamaCare, a cloud-based patient access platform for specialty medications, today announced that it has closed an oversubscribed $17 million Series B investment round led by new investor Questa Capital.
– Questa…
Continue Reading
Despite being the most common form of cardiac arrhythmia, atrial fibrillation (AFib) is a condition that often goes undiagnosed and/or untreated. The condition, which often accompanies other health problems like hypertension and heart failure,…
Continue Reading
Healthcare providers’ failure to properly coordinate care often leads to the duplication of tests and services, medication errors, delayed or missed diagnoses, and patient confusion and frustration — and this uncoordinated care ends up…
Continue Reading
What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc….
Continue Reading
What You Should Know:
– Daffodil Health, a healthcare technology company, has secured $4.6M in seed funding to tackle the multi-billion dollar problem of wasted healthcare administrative costs led by Maverick Ventures with participation from…
Continue Reading
What You Should Know:
– Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
– The investment aims…
Continue Reading
Fay Co-Founders Sammy Faycurry (CEO) and Mark Stefanski (CTO)
What You Should Know:
– Fay, a San Francisco, CA-based company that focuses on increasing access to medical nutrition therapy emerges from stealth with $25M in funding…
Continue Reading
SmarterDx closed a $50 million Series B funding round on Tuesday, bringing the startup’s total funding to date to $71 million. The New York-based company is a healthcare AI startup that provides clinical review…
Continue Reading
Sameer Sabir, Chief Executive Officer of Brixton Biosciences
What You Should Know:
– Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with…
Continue Reading
